Oncology Company Granted FDA Fast Track Designation For Pancreatic Cancer Treatment Development
Immuneering Corporation Granted FDA Fast Track Designation for IMM-1-104 in First-Line Pancreatic Cancer.
Disclaimer: The information provided in this article is intended for informational use only and should not be construed as medical or professional advice. Always consult a healthcare provider for medical guidance.
Real-time information is available daily at https://stockregion.net